Patents by Inventor Jesus Miranda
Jesus Miranda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11021114Abstract: A door trim assembly includes an armrest, a pull handle, including a receiver, and a bracket joining the armrest and the pull handle. The bracket includes a connection feature that engages with the receiver. The bracket is cantilevered to the pull handle and includes a second end with an abutment surface engaging the armrest.Type: GrantFiled: August 14, 2018Date of Patent: June 1, 2021Assignee: Ford Global Technologies, LLCInventors: Jesus Miranda Lujan, Sandra Cristina Alvarado Gomez, Joseph Andrew Hickey, Bhavani S. Thota, Linh Doan
-
Publication number: 20200055463Abstract: A door trim assembly includes an armrest, a pull handle, including a receiver, and a bracket joining the armrest and the pull handle. The bracket includes a connection feature that engages with the receiver. The bracket is cantilevered to the pull handle and includes a second end with an abutment surface engaging the armrest.Type: ApplicationFiled: August 14, 2018Publication date: February 20, 2020Inventors: Jesus Miranda Lujan, Sandra Cristina Alvarado Gomez, Joseph Andrew Hickey, Bhavani S. Thota, Linh Doan
-
Publication number: 20180076758Abstract: Three-dimensional photovoltaic assemblies capable of greater electric power output and more consistent power profiles than flat photovoltaic systems of the prior art with the same footprint are disclosed. The assemblies are comprised of a plurality of elongated photovoltaic modules arranged to project radially outward from a central trunk. In some embodiments, elongated photovoltaic modules comprise an elongated prismatic body having a multi-sided polygonal cross-section, wherein the lateral sides of the elongated body define non-parallel rectangular panels and photovoltaic cells are mounted on at least two of the lateral sides or panels of the elongated body. The photovoltaic cells on the plurality of elongated photovoltaic modules can be exposed to the radiant energy of the sun at a plurality of angles of incidence at any given point in time of day.Type: ApplicationFiled: September 12, 2016Publication date: March 15, 2018Inventor: Jesus Miranda
-
Patent number: 8827516Abstract: An interior grab handle and lamp assembly for a vehicle including a bracket configured for attachment by fasteners to a structural roof member. The bracket is disposed on an back side surface of a headliner. An elongate handle is operably connected to the bracket via first and second mounting members disposed on an visible surface of the headliner. A light source is operably connected with an intermediate portion of the bracket. The light source is disposed on the visible surface of the headliner between the first and second mounting members.Type: GrantFiled: November 30, 2011Date of Patent: September 9, 2014Assignee: Ford Global Technologies, LLCInventors: John Andrew Stakoe, Chi Li, Bhavani Thota, Guillermo Alanis, Jesus Miranda Lujan
-
Publication number: 20130135884Abstract: An interior grab handle and lamp assembly for a vehicle including a bracket configured for attachment by fasteners to a structural roof member. The bracket is disposed on an back side surface of a headliner. An elongate handle is operably connected to the bracket via first and second mounting members disposed on an visible surface of the headliner. A light source is operably connected with an intermediate portion of the bracket. The light source is disposed on the visible surface of the headliner between the first and second mounting members.Type: ApplicationFiled: November 30, 2011Publication date: May 30, 2013Applicant: FORD GLOBAL TECHNOLOGIES, LLCInventors: John Andrew Stakoe, Chi Li, Bhavani Thota, Guillermo Alanis, Jesus Miranda Lujan
-
Patent number: 6974588Abstract: A transdermal patch for administering a volatile liquid drug, such as nicotine, transdermally to a patient comprising a four-layer laminated composite of: a top drug impermeable backing layer; a pressure sensitive silicone adhesive layer containing the drug; a pressure sensitive acrylic adhesive layer also containing the drug; and a removable siliconized release liner layer. Also disclosed is a method for treating a person for nicotine dependence and particularly for treating a woman for nicotine dependence.Type: GrantFiled: December 7, 1999Date of Patent: December 13, 2005Assignee: Elan Pharma International LimitedInventors: Jesus Miranda, Charles J. Betlach, II
-
Publication number: 20040137004Abstract: A protein-in-adhesive patch for transcutaneous immunization is described with at least four different components: (i) backing layer; (ii) pressure-sensitive adhesive adhering to the backing layer; (iii) at last one immunologically-active protein of an immunogenic formulation applied to the pressure-sensitive adhesive layer opposite the backing layer and/or incorporated in the pressure-sensitive adhesive layer such that the at least one protein is in contact with adhesive; and (iv) stabilizer which maintains the immunological activity of the at least one protein under ambient conditions.Type: ApplicationFiled: March 12, 2004Publication date: July 15, 2004Inventors: Gregory M Glenn, Jianmei Yu, Mervyn L Hamer, Jesus Miranda, Christopher L Adams
-
Publication number: 20040120995Abstract: A transdermal delivery device comprising a multi-phase matrix which includes a solid liquid-retaining member and associated therewith pergolide in liquid form, for example, a transdermal delivery device comprising a barrier layer affixed to one face of the matrix and having an exposed face, the exposed face having affixed thereto a mounting layer, and the other face of the matrix having affixed thereto a removable layer, an example of the liquid-retaining member being an absorbent material, for example, a natural or synthetic fiber gauze, a non-woven medical basorbent, a natural sponge, and a synthetic sponge.Type: ApplicationFiled: September 30, 2003Publication date: June 24, 2004Inventors: Debra A Martin, Jesus Miranda, Adolfo Leonel Vanegas
-
Publication number: 20010053383Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.Type: ApplicationFiled: May 21, 2001Publication date: December 20, 2001Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 6235306Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.Type: GrantFiled: March 23, 1999Date of Patent: May 22, 2001Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 6221383Abstract: A blend of at least two polymers, or at least one polymer and a soluble polyvinylpyrrolidone, in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin. According to the invention, soluble polyvinylpyrrolidone can be used to prevent crystallization of the drug, without affecting the rate of drug delivery from the pressure-sensitive adhesive composition.Type: GrantFiled: May 25, 1999Date of Patent: April 24, 2001Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 6024976Abstract: A blend of at least two polymers, or at least one polymer and a soluble polyvinylpyrrolidone, in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin. According to the invention, soluble polyvinylpyrrolidone can be used to prevent crystallization of the drug, without affecting the rate of drug delivery from the pressure-sensitive adhesive composition.Type: GrantFiled: August 11, 1997Date of Patent: February 15, 2000Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 5958446Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.Type: GrantFiled: May 4, 1995Date of Patent: September 28, 1999Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 5656286Abstract: A blend of at least two polymers, or at least one polymer and a soluble polyvinylpyrrolidone, in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin. According to the invention, soluble polyvinylpyrrolidone can be used to prevent crystallization of the drug, without affecting the rate of drug delivery from the pressure-sensitive adhesive composition.Type: GrantFiled: January 7, 1994Date of Patent: August 12, 1997Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 5474783Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.Type: GrantFiled: June 27, 1991Date of Patent: December 12, 1995Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 5271940Abstract: A transdermal delivery device has a reservoir containing an active compound, which is kept separate from the delivery layers of the device until administration. At the time of administration, the reservoir is laminated to the delivery layers, or is ruptured to place the active compound, vehicle, and/or permeation enhancers in contact with the delivery layers, which results in administration of the active compound to the skin after a delay period.Type: GrantFiled: March 27, 1992Date of Patent: December 21, 1993Assignee: Cygnus Therapeutic SystemsInventors: Gary W. Cleary, Kenneth J. Colley, Jesus Miranda
-
Patent number: 5091186Abstract: A transdermal drug delivery system in which drug delivery is biphasic is provided. Drug is delivered at a therapeutically effective rate during an initial, delivery phase, typically of about 10 to 14 hours, followed by a subsequent, secondary phase during which virtually no drug is delivered. Substantially all of the drug initially loaded into the device is delivered within the initial, delivery phase.Type: GrantFiled: August 15, 1989Date of Patent: February 25, 1992Assignee: Cygnus Therapeutic SystemsInventors: Jesus Miranda, Gary W. Cleary
-
Patent number: 4915950Abstract: A method for making transdermal drug delivery devices is provided which includes: laminating an adsorbent source layer to a pressure-sensitive, pharmaceutically acceptable contact adhesive; depositing a drug in liquid form on one face of the source layer; laminating an anchor adhesive layer to the opposing face of the source layer; and applying a drug-impermeable backing layer to the anchor adhesive, which backing layer then defines the upper surface of the device. The invention also encompasses transdermal drug delivery devices having a source layer in contact with and contained between anchor and contact adhesive layers, with a backing layer adjacent the anchor adhesive defining the upper surface of the device.Type: GrantFiled: July 5, 1988Date of Patent: April 10, 1990Assignee: Cygnus Research CorporationInventors: Jesus Miranda, Gary W. Cleary